The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...
With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector ...
Morning Overview on MSN
Quantum-powered proteins could launch a shocking new biotech era
Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...
Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...
Scientists at the Broad Institute and Mass General Brigham have built a generative AI model that creates short DNA segments ...
The National Institutes of Health failed to protect brain scans that an international group of fringe researchers used to ...
Skoltech researchers and their colleagues from Ludwig Maximilian University of Munich, Germany, Nanjing University of China, ...
X Health System, a precision wellness company focused on data-driven human optimization, today announced the addition of 10X MitoScreen (TM), an advanced mitochondrial health assessment, through a ...
Researchers developed a CRISPR and single-molecule microarray test that quantifies Candida auris and detects antifungal resistance in under 40 minutes. The assay provides rapid, precise results from ...
Mira is bringing its version of Oxford Cancer Biomarkers' PGx test to the US in the newly launched ToxNav Advantage assay.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results